CompletedNot Applicable

Left Main Percutaneous Coronary Intervention Registry in Istanbul Medipol University Hospital

Turkey (Türkiye)3,620 participantsStarted 2018-06-01

Plain-language summary

This hospital-based registry study at Istanbul Medipol University Hospital focuses on documenting and analyzing the clinical and demographic characteristics, procedural-related aspects, and both short and long-term outcomes of patients undergoing left main coronary artery percutaneous coronary intervention (PCI). The study aims to identify predictors for adverse clinical outcomes in patients treated for left main coronary artery disease.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients undergoing any PCI procedure(s) in given timeframe will be included in this registry Exclusion Criteria: * Patients with no informed consent

What they're measuring

Incidence of Major Adverse Cardiac Events (MACE) within One Year Following Left Main Coronary Artery PCI

Timeframe: up to 1 month, 3 months, 1 year

Trial details

NCT IDNCT06262971

SponsorMedipol University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Coronary Artery Disease trials